Autoimmune encephalitides (AIE) comprise a group of inflammatory diseases of the central
nervous system (CNS), which can be further characterized by the presence of different …

We have reviewed the literature of immune therapy in autoimmune encephalitis associated
with antibodies to cell surface antigens including N-methyl-D-aspartate receptor (NMDAR) …

Objective: To report the presentation, main syndromes, human leukocyte antigen (HLA)
association, and immunoglobulin G (IgG) subclass in the anti-IgLON5 disease: a disorder …

We recently reported a novel neurological syndrome characterized by a unique NREM and
REM parasomnia with sleep apnea and stridor, accompanied by bulbar dysfunction and …

Objective: To describe the phenotypes, treatment response, and outcome of IgLON5
autoimmunity. Methods: Archived serum and CSF specimens from 367 patients known to …

Background and Objectives Anti-IgLON5 disease is a recently described neurologic disease
that shares features of autoimmunity and neurodegeneration. Abnormal movements appear …

Sleep disorders in people with autoimmune encephalitis have received little attention,
probably overshadowed by the presence of other neurological and psychiatric symptoms in …

Recently, several autoimmune neurological diseases have been defined by the presence of
autoantibodies against different antigens of the nervous system. These autoantibodies have …

Abstract Background Antibodies against IgLON5, a neuronal adhesion protein of unknown
function, are markers of a novel neurological disorder termed anti-IgLON5 syndrome. The …

Anti-IgLON5 disease is a relatively new neurological entity with the first cases reported in
2014. So far, less than 70 articles on this topic have been published. Due to its unspecific …